Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.07
MDRX's Cash to Debt is ranked lower than
64% of the 1702 Companies
in the Global Health Information Services industry.

( Industry Median: 20.91 vs. MDRX: 0.07 )
MDRX' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.07

Equity to Asset 0.50
MDRX's Equity to Asset is ranked higher than
55% of the 1664 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. MDRX: 0.50 )
MDRX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.96
Current: 0.5

0.3
0.96
Interest Coverage 6.58
MDRX's Interest Coverage is ranked lower than
58% of the 1085 Companies
in the Global Health Information Services industry.

( Industry Median: 434.43 vs. MDRX: 6.58 )
MDRX' s 10-Year Interest Coverage Range
Min: 0.82   Max: 9999.99
Current: 6.58

0.82
9999.99
F-Score: 2
Z-Score: 1.50
M-Score: -2.82
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 9.46
MDRX's Operating margin (%) is ranked higher than
79% of the 1673 Companies
in the Global Health Information Services industry.

( Industry Median: 5.43 vs. MDRX: 9.46 )
MDRX' s 10-Year Operating margin (%) Range
Min: -668.22   Max: 9.97
Current: 9.46

-668.22
9.97
Net-margin (%) 5.10
MDRX's Net-margin (%) is ranked higher than
72% of the 1672 Companies
in the Global Health Information Services industry.

( Industry Median: 3.67 vs. MDRX: 5.10 )
MDRX' s 10-Year Net-margin (%) Range
Min: -592.1   Max: 8.05
Current: 5.1

-592.1
8.05
ROE (%) 4.98
MDRX's ROE (%) is ranked higher than
64% of the 1630 Companies
in the Global Health Information Services industry.

( Industry Median: 6.75 vs. MDRX: 4.98 )
MDRX' s 10-Year ROE (%) Range
Min: -424.73   Max: 9.87
Current: 4.98

-424.73
9.87
ROA (%) 2.92
MDRX's ROA (%) is ranked higher than
65% of the 1690 Companies
in the Global Health Information Services industry.

( Industry Median: 3.50 vs. MDRX: 2.92 )
MDRX' s 10-Year ROA (%) Range
Min: -356.71   Max: 4.39
Current: 2.92

-356.71
4.39
ROC (Joel Greenblatt) (%) 75.78
MDRX's ROC (Joel Greenblatt) (%) is ranked higher than
82% of the 1673 Companies
in the Global Health Information Services industry.

( Industry Median: 30.08 vs. MDRX: 75.78 )
MDRX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -3286.45   Max: 335.02
Current: 75.78

-3286.45
335.02
Revenue Growth (%) 21.20
MDRX's Revenue Growth (%) is ranked higher than
91% of the 1401 Companies
in the Global Health Information Services industry.

( Industry Median: 5.80 vs. MDRX: 21.20 )
MDRX' s 10-Year Revenue Growth (%) Range
Min: -28.7   Max: 39.2
Current: 21.2

-28.7
39.2
EBITDA Growth (%) -27.30
MDRX's EBITDA Growth (%) is ranked lower than
52% of the 1136 Companies
in the Global Health Information Services industry.

( Industry Median: 6.90 vs. MDRX: -27.30 )
MDRX' s 10-Year EBITDA Growth (%) Range
Min: -70.6   Max: 105.3
Current: -27.3

-70.6
105.3
» MDRX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MDRX Guru Trades in Q3 2013

Columbia Wanger 12,543,700 sh (+79.3%)
Third Avenue Management 1,380,244 sh (+22.02%)
Chuck Royce 1,069,300 sh (+7.33%)
Vanguard Health Care Fund 8,542,653 sh (+2.29%)
Michael Price 477,500 sh (unchged)
RS Investment Management 4,178,052 sh (-0.05%)
Steven Cohen 114,713 sh (-1.45%)
Joel Greenblatt 17,732 sh (-20.82%)
» More
Q4 2013

MDRX Guru Trades in Q4 2013

Jim Simons 19,965 sh (New)
RS Investment Management 5,829,716 sh (+39.53%)
Chuck Royce 1,242,300 sh (+16.18%)
Third Avenue Management 1,535,465 sh (+11.25%)
Steven Cohen 124,794 sh (+8.79%)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 8,542,653 sh (unchged)
Columbia Wanger 12,543,700 sh (unchged)
Joel Greenblatt Sold Out
» More
Q1 2014

MDRX Guru Trades in Q1 2014

Lee Ainslie 5,255,290 sh (New)
Steven Cohen 400,000 sh (+220.53%)
Third Avenue Management 1,708,718 sh (+11.28%)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 8,542,653 sh (unchged)
Columbia Wanger 12,543,700 sh (unchged)
Jim Simons Sold Out
RS Investment Management 5,186,573 sh (-11.03%)
Chuck Royce 1,013,100 sh (-18.45%)
» More
Q2 2014

MDRX Guru Trades in Q2 2014

Third Avenue Management 2,025,793 sh (+18.56%)
RS Investment Management 6,054,879 sh (+16.74%)
Chuck Royce 1,143,700 sh (+12.89%)
Vanguard Health Care Fund 8,542,653 sh (unchged)
Michael Price 477,500 sh (unchged)
Lee Ainslie Sold Out
Columbia Wanger 10,111,800 sh (-19.39%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2014-06-30 Sold Out 1.3%$14.44 - $18.29 $ 14.78-5%0
Lee Ainslie 2014-03-31 New Buy1.3%$14.71 - $19.43 $ 14.78-14%5255290
Joel Greenblatt 2013-12-31 Sold Out 0.01%$13.83 - $15.38 $ 14.780%0
Joel Greenblatt 2013-09-30 Reduce -20.82%$13.12 - $16.26 $ 14.78-2%17732
Vanguard Health Care Fund 2013-06-30 Add 108.41%0.21%$12.58 - $14.09 $ 14.7810%8351463
Joel Greenblatt 2013-06-30 Reduce -43.45%0.01%$12.58 - $14.09 $ 14.7810%22394
Joel Greenblatt 2012-12-31 Reduce -44.58%0.03%$9.08 - $13.9 $ 14.7822%45460
Vanguard Health Care Fund 2012-12-31 Add 55.24%0.03%$9.08 - $13.9 $ 14.7822%3787009
Joel Greenblatt 2012-09-30 Reduce -31.85%0.03%$8.99 - $12.42 $ 14.7842%82022
Michael Price 2012-06-30 New Buy0.63%$9.41 - $16.69 $ 14.7820%400000
Ron Baron 2012-06-30 Sold Out 0.13%$9.41 - $16.69 $ 14.7820%0
Vanguard Health Care Fund 2012-06-30 New Buy0.13%$9.41 - $16.69 $ 14.7820%2439400
Joel Greenblatt 2012-06-30 Add 442.49%0.08%$9.41 - $16.69 $ 14.7820%120363
Ron Baron 2012-03-31 Reduce -20.47%0.04%$16.68 - $21.47 $ 14.78-17%1305220
Joel Greenblatt 2012-03-31 New Buy0.03%$16.68 - $21.47 $ 14.78-17%22187
George Soros 2011-06-30 Sold Out $18.48 - $22.71 $ 14.78-27%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.04
MDRX's P/B is ranked higher than
72% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 2.95 vs. MDRX: 2.04 )
MDRX' s 10-Year P/B Range
Min: 0.79   Max: 8.74
Current: 2.04

0.79
8.74
P/S 1.93
MDRX's P/S is ranked higher than
66% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 2.37 vs. MDRX: 1.93 )
MDRX' s 10-Year P/S Range
Min: 0.94   Max: 7.12
Current: 1.93

0.94
7.12
EV-to-EBIT -34.14
MDRX's EV-to-EBIT is ranked lower than
51% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 34.84 vs. MDRX: -34.14 )
MDRX' s 10-Year EV-to-EBIT Range
Min: 16.8   Max: 1386.5
Current: -34.14

16.8
1386.5
Shiller P/E 289.30
MDRX's Shiller P/E is ranked higher than
70% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 9999.00 vs. MDRX: 289.30 )
MDRX' s 10-Year Shiller P/E Range
Min: 29.45   Max: 400.8
Current: 289.3

29.45
400.8
Current Ratio 1.05
MDRX's Current Ratio is ranked lower than
58% of the 1308 Companies
in the Global Health Information Services industry.

( Industry Median: 2.04 vs. MDRX: 1.05 )
MDRX' s 10-Year Current Ratio Range
Min: 0.98   Max: 23.84
Current: 1.05

0.98
23.84
Quick Ratio 1.05
MDRX's Quick Ratio is ranked lower than
56% of the 1308 Companies
in the Global Health Information Services industry.

( Industry Median: 1.91 vs. MDRX: 1.05 )
MDRX' s 10-Year Quick Ratio Range
Min: 0.73   Max: 23.25
Current: 1.05

0.73
23.25

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.51
MDRX's Price/DCF (Projected) is ranked higher than
84% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 8.28 vs. MDRX: 1.51 )
MDRX' s 10-Year Price/DCF (Projected) Range
Min: 0.85   Max: 6.32
Current: 1.51

0.85
6.32
Price/Median PS Value 0.54
MDRX's Price/Median PS Value is ranked higher than
95% of the 1830 Companies
in the Global Health Information Services industry.

( Industry Median: 1.20 vs. MDRX: 0.54 )
MDRX' s 10-Year Price/Median PS Value Range
Min: 0.33   Max: 9.15
Current: 0.54

0.33
9.15
Earnings Yield (Greenblatt) 0.50
MDRX's Earnings Yield (Greenblatt) is ranked lower than
62% of the 1445 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. MDRX: 0.50 )
MDRX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 5.9
Current: 0.5

0.1
5.9
Forward Rate of Return (Yacktman) -9.47
MDRX's Forward Rate of Return (Yacktman) is ranked lower than
52% of the 1267 Companies
in the Global Health Information Services industry.

( Industry Median: 5.90 vs. MDRX: -9.47 )
MDRX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -10.4   Max: 69.3
Current: -9.47

-10.4
69.3

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, AH, QSII » details
Traded in other countries:AL21.Germany
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes. The Company provides a variety of integrated clinical software applications for hospitals, physician practices and post-acute organizations. For hospitals and health systems these applications include its Sunrise Enterprise suite of clinical solutions, comprising a full acute care Electronic Health Record, integrated with financial/administrative solutions including performance management and revenue cycle/access management. The Company's acute care solutions include modules of the Sunrise suite that are available on a stand-alone basis, as well as additional stand-alone solutions including Emergency Department Information System, care management and discharge management. Allscripts IT Outsourcing enables hospitals and physician groups to concentrate on their core mission while using IT to improve clinical, financial and operational outcomes. Allscripts Remote Hosting helps healthcare organizations manage their complex healthcare IT solutions infrastructure while freeing up the physical space, resources and costs associated with maintaining computer servers and deploying client-based applications on-site. The Company also provides a variety of solutions for home care, hospice, skilled nursing, and other post-acute organizations; these range from a fully integrated EHR and financial management solution to Referral Management. Clients in every care setting can leverage Allscripts mobile solutions to deliver remote access to EHR and other capabilities on a wide variety of mobile devices including iPad, iPhone, BlackBerry, Android and Windows Mobile smartphones. Additional add-on applications include its Patient Portal, Patient Kiosk, Prenatal, and Analytics solutions. The Company's community-based solutions for hospitals and health systems, provided in partnership with dbMotion, deliver meaningful health information exchange and enable information connectivity across entire communities of providers, regardless of which technology vendor they use, helping its clients to compete in an evolving marketplace. The Company reports its financial results utilizing three business segments: clinical solutions, hospital solutions and health solutions. The Company's clinical solutions segment presents the operations of its ambulatory solutions for physician practices; hospital solutions reflects the operations, subsequent to the completion of its merger with Eclipsys Corporation on August 24, 2010, of the Company's acute care hospital solutions acquired in the merger; and health solutions reflects the operations of its acute and post-acute solutions for health systems. It has competition from several types of organizations, including providers of practice management solutions, electronic prescribing soluti
» More Articles for MDRX

Headlines

Articles On GuruFocus.com
Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
American Insider Trades: March 8-15 Mar 15 2013 
The Barclays Triggers More Insider Buying Mar 13 2013 
Allscripts-Misys Reports 5 Insider Buys the Day Before Barclays Conference Mar 13 2013 
Edward Owens’ 3 Biggest Stock Increases Feb 05 2013 
Larry Robbins Grows in Tenet Healthcare Shares Oct 24 2012 
Weekly Guru Bargains Highlights: ANR, CHK, MDRX, APAGF, CLWR Apr 30 2012 
5 'Very Cheap' Buy Ideas Mar 04 2012 
Weekly CFO Sells Highlight: MDRX, JDSU, CAVM, S, SPW Feb 26 2011 

More From Other Websites
Cerner Takes Medical IT Drive Global With Siemens Buy Aug 21 2014
Baylor Scott & White Health selects Allscripts dbMotion interoperability and population health... Aug 20 2014
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Financials Aug 15 2014
Allscripts Healthcare, Clinical Architecture Extend Alliance Aug 15 2014
Allscripts Healthcare (MDRX) Driven by Bookings Growth Aug 13 2014
Allscripts and Clinical Architecture expand partnership to enhance terminology management for HIE... Aug 13 2014
Apple makes new iPads, sees fitness band as medical Aug 12 2014
Exclusive: Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014
EXCLUSIVE - Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014
Exclusive - Apple prepares Healthkit rollout amid tangled regulatory web Aug 12 2014
Allscripts among best ambulatory EHR vendors according to Black Book Rankings data Aug 11 2014
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 10-Q, Quarterly Report Aug 08 2014
Allscripts Healthcare Q2 Earnings Beat but Revenues Miss Aug 08 2014
Allscripts Healthcare Solutions, Inc. Earnings Call scheduled for 4:30 pm ET today Aug 07 2014
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial... Aug 07 2014
Allscripts announces second quarter 2014 results Aug 07 2014
Q2 2014 Allscripts Healthcare Solutions, Inc. Earnings Release - After Market Close Aug 07 2014
Practice Fusion buys startup Ringadoc in telemedicine play Aug 06 2014
Cerner To Buy Siemens Health IT Business For $1.3 Billion Aug 05 2014
Allscripts named Microsoft's U.S. Health Provider Partner of the Year Jul 31 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK